FREE ON-DEMAND WEBINAR—Key Considerations for Nonclinical AAV Gene Therapy
From Screening to PCR Analysis
In this webinar on AAV gene therapy, we explore pre-existing immunity challenges, vector targets, biodistribution, and the role of PCR analysis in assessing therapy efficacy and safety.
Also included are case studies that highlight the delicate balance between innovation and regulatory compliance.
You may also be interested in the following:
The Altascientist
• qPCR and ddPCR—Leading-Edge Analysis for Gene Therapy Programs
• Nonclinical Studies in Cell and Gene Therapy
Webpages
• Bioanalytical Services
• Preclinical Services